XBIT

XBiotech Inc.

Healthcare · Biotechnology

$179.11 sample

-0.15 (-0.08%) 1D

Market cap

$786.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-03

Alerts

8

Price$179.11 +10.50% 3M daily closessample

184.67157.36

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Financial Officer
Sep 30INSInsider buy: 10% owner
Sep 23INSInsider sell: General Counsel
Sep 18INSInsider sell: 10% owner
Sep 11INSInsider sell: Chief Financial Officer
Sep 03SEC8-K filed: material event
Aug 31INSInsider sell: Chief Financial Officer
Aug 24INSInsider sell: Director

Sign up to see the real XBIT record →

Company facts

SEC EDGAR registration

Name: XBiotech Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +11sample, -100 to +100
Reporting currency: USD

Who is positioning in XBIT

sample

Insiders: 7 insider transactions over 90 days, net selling, $475.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 28 funds hold $6.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.8B +22.5% y/y

Q4 2024Q3 2026

Inventory$11.8B +6.4% y/y

Q4 2024Q3 2026

Accounts receivable$8.9B +7.5% y/y

Q4 2024Q3 2026

Total debt$24.6B +16.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $718.2B +8.1% 3M
Sample peer B: $631.1B -4.3% 3M
Sample peer C: $730.7B +13.5% 3M
Sample peer D: $660.0B +4.4% 3M
Sample peer E: $651.7B +13.3% 3M